REAP Financial Group’s Astera Labs ALAB Stock Holding History

REAP Financial Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-150	Closed	-$13.6K	–	559
2025 Q2	$13.6K	Buy	+150	New	+$11.9K	﹤0.01%	367

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

REAP Financial Group's ALAB Position: Q3 2025 in Review

REAP Financial Group sold out of Astera Labs (ALAB) in Q3 2025, closing a stake of 150 shares — an estimated $13.6K sold.

REAP Financial Group first reported a position in ALAB in Q2 2025 and held it in 1 quarter. The position peaked at $13.6K in Q2 2025. 657 funds tracked by Wall St. Rank hold ALAB as of Q3 2025.

REAP Financial Group reported no remaining Astera Labs position as of Q3 2025 after selling out during the quarter.
REAP Financial Group sold 150 Astera Labs shares in Q3 2025, an estimated $13.6K.
REAP Financial Group first reported a position in Astera Labs in Q2 2025 and held it in 1 quarter.
REAP Financial Group's Astera Labs position peaked at $13.6K in Q2 2025.
657 funds tracked by Wall St. Rank held Astera Labs as of Q3 2025.

Based on REAP Financial Group's 13F filing for Q3 2025, filed 6 Nov 2025.